Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: Studies in the rat and implications for preeclampsia

Hypertension in Pregnancy

Volumn 15, Issue 2, 1996, Pages 147-169

  Baylis, Chris ^a,d   Suto, Tamas ^a,b   Conrad, Kirk ^c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ENZYME ACTIVITY; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; MATERNAL HYPERTENSION; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; REVIEW; URINARY EXCRETION;

EID: 0029789972     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015699     Document Type: Review

References (132)

1. De Swiet M. The physiology of normal pregnancy. In: Rubin PC, ed. Handbook of Hypertension: Hypertension in Pregnancy. vol 10. Elsevier, 1988: 1-9.
2. Lindheimer MD, Katz AI. Normal and abnormal pregnancy. In: Arieff AI, DeFronzo R, eds. Fluid, Electrolyte and Acid-Base Disorders. New York: Churchill Livingstone, 1985: 1041-80.
3. Chesley LC. Blood pressure and circulation. In: Chesley LC, ed. Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Crofts, 1978: 119-54.
4. Bay WH, Ferris TF. Factors controlling plasma renin and aldosterone during pregnancy. Hypertension 1979;1:410-5.
5. Gant NF, Whalley PJ, Everett R, Worley R, Macdonald PC. Control of vascular reactivity in pregnancy. Am J Kid Dis 1987;9:303-7.
6. Davison JM, Hytten FE. Glomerular filtration during and after pregnancy. J Obstet Gynaecol British Commonwealth 1974;81:588-95.
7. Davison JM, Dunlop W. Renal haemodynamics and tubular function in normal human pregnancy. Kidney Int 1980;18:152-61.
8. Baylis C. Glomerular filtration and volume regulation in gravid animal models. In: Lindheimer MD, Davison JM, eds. Baillieres Clinical Obstetrics and Gynecology. vol 8, 2nd ed. London: Bailliere Tindall, 1994: 235-64.
9. Ferris TF. Prostanoids in normal and hypertensive pregnancy. In: Rubin PC, ed. Handbook of Hypertension. vol 10: Hypertension in Pregnancy. Elsevier, 1988: 102-17.
10. Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. J Clin Invest 1986;77:236-45.
11. Baylis C. Renal effects of cyclooxygenase inhibition in the pregnant rat. Am J Physiol 1987;253:F158-63.
12. Baylis C, Engels K, Harton P, Samsell L. The acute effects of endothelial derived relaxing factor (EDRF) blockade in the normal, conscious rat are not due to angiotensin II (AII). Am J Physiol 1993;264:F74-8.
13. Fournier A, El Esper GN, Lalau JD, Westeel PF, Makdassi R, Fievet P, DeBold AJ. Atrial natriuretic factor in pregnancy and pregnancy-induced hypertension. Can J Physiol Pharmacol 1991;69:1601-8.
14. Gregoire I, El Esper N, Gondry J, Boitte F, Fievet P, Makdassi R, Westeel PF. Plasma atrial natriuretic factor and urinary excretion of a ouabain displacing factor and dopamine in normotensive pregnant women before and after delivery. Am J Obstet Gynecol 1990;162:71-6.
15. Masilamani S, Baylis C. Pregnant rats are refractory to the natriuretic actions of ANP. Am J Physiol (Regul) 1994;267:R1611-6.
16. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis and endogenous roles of nitric oxide. Pharm Rev 1991;43:109-42.
17. G-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am J Physiol 1992; 262:R1137-44.
18. Cabrera C, Bohr D. The role of nitric oxide in the central control of blood pressure. Biochem Biophys Res Commun 1995;206:77-81.
19. Tojo A, Gross SS, Zhang L, Tisher CC, Schmidt HHHW, Wilcox CS, et al. Immunocytochemical localization of distinct isoforms of NO synthase in the juxtaglomerular apparatus of the normal kidney. J Am Soc Nephrol 1994;4:1438-47.
20. Bachmann S, Mundel P. NO in the kidney: synthesis, localization and function. Am J Kid Dis 1994;24:112-29.
21. Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNA's encoding two iNOS in rat kidney. Kidney Int 1994;46:653-65.
22. Morrissey JJ, Mccracken R, Kaneto H, Vahaskari M, Montani D, Klarh S. Location of an inducible NO synthase mRNA in the normal kidney. Kidney Int 1994;45:998-1005.
23. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor (EDRF) controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1990;1:875-81.
24. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323: 22-7.
25. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
26. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993;11:1375-80.
27. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992;19:619-25.
28. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90: 278-81.
29. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992;20: 298-303.
30. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens 1993;11:639-45.
31. Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol 1994;267:F331-46.
32. Morris SM, Jr, Billiar TR. New insights into the regulation of inducible NO synthesis. Am J Physiol 1994;266:E1-11.
33. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992;20(S12): S60-2.
34. Ueno SI, Sano A, Kotani K, Kondoh K, Kakimoto Y. Distribution of free methylarginine in rat tissues and in the bovine brain. J Neurochem 1992;59:2012-6.
35. Visek WJ. Arginine needs, physiological state and usual diets: a reevaluation. J Nutr 1986;116:36-46.
36. Milner JA. Metabolic aberrations associated with arginine deficiency. J Nutr 1985; 115:516-23.
37. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-6.
38. Nathan C, Xie Q. Regulation of biosynthesis of NO. J Biol Chem 1994;269:13725-8.
39. NOX V) do not predict renal vascular NO production. Kidney Int 1995;48:1272-7.
40. Wong Sk-F, Garbers DL. Receptor guanylyl cyclases. J Clin Invest 1992;90: 299-305.
41. Ujiie K, Drewett JG, Yuen PST, Star RA. Differential expression of mRNA for guanylyl cyclase-linked EDRF receptor subunits in rat kidney. J Clin Invest 1993; 91:730-4.
42. Conrad KP, Vernier KA. Plasma levels, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol 1989;257:R847-53.
43. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993;7:566-71.
44. Engels K, Deng A, Samsell L, Hill C, Baylis C. Increased nitric oxide (NO) production in normal pregnancy is resistant to inhibition. J Am Soc Nephrol 1993; 4:548A.
45. Umans JG, Lindheimer MD, Barron WM. Pressor effect of endothelium derived relaxing factor inhibition in conscious virgin and gravid rats. Am J Physiol 1990; 259:F293-6.
46. Allen R, Castro L, Arora C, Hrakow D, Huang S, Platt L. Endothelium-derived relaxing factor inhibition and the pressor response to norepinephrine in the pregnant rat. Obstet Gynecol 1994;83:92-6.
47. Molnar M, Hertelendy F. Nw-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992;166:1560-7.
48. Weiner C, Martinez E, Zhu, LK, Ghodsi A, Chestnut D. In vitro release of endothelium-derived relaxing factor by acetylcholine is increased during the guinea pig pregnancy. Am J Obstet Gynecol 1989;161:1599-1605.
49. Kim TH, Weiner CP, Thompson LP. Effect of pregnancy on contraction and endothelium-mediated relaxation of renal and mesenteric arteries. Am J Physiol 1994;267:H41-7.
50. Weiner CP, Martinez E, Chestnut DH, Ghodsi A. Effect of pregnancy on uterine and carotid artery response to norepinephrine, epinephrine, and phenylephrine in vessels with documented functional endothelium. Am J Obstet Gynecol 1989;161:1605-10.
51. Weiner CP, Thompson LP, Liu KZ, Herrig JE. Pregnancy reduced serotonin-induced contraction of guinea pig uterine and carotid arteries. Am J Physiol 1992;263: H1764-9.
52. Weiner CP, Thompson LP, Liu, KZ, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol 1992;166:1171-81.
53. St-Louis J, Sicotte B. Prostaglandin- or endothelium-mediated vasodilation is not involved in the blunted responses of blood vessels to vasoconstrictors in pregnant rats. Am J Obstet Gynecol 1992;166:684-92.
54. Griggs KC, Conrad KP, Mackey K, McLaughlin M. Endothelial modulation of renal interlobar arteries from pregnant rats. Am J Physiol 1993;265:F309-15.
55. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994;171:838-43.
56. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 1994;205:905-10.
57. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol 1995;268:H377-83.
58. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244:19-22.
59. Garland HO, Atherton JC, Baylis C, Morgan MRA, Milne CM. Hormone profiles for progesterone, estradiol, prolactin, plasma renin activity, aldosterone and corticosterone during pregnancy and pseudopregnancy in two strains of rats; correlation with renal studies. J Endocrinol 1987;113:435-44.
60. Milner JA, Visek WJ. Orotic aciduria in the female rat and its relation to dietary arginine. J Nutr 1978;108:1281-8.
61. Raij L. Glomerular thrombosis in pregnancy: role of the L-arginine-nitric oxide pathway. Kidney Int 1994;45:775-81.
62. Pau MY, Milner JA. Arginine deficiency during gestation and lactation in the rat. J Nutr 1981;111:184-93.
63. Raij L, Baylis C. Nitric oxide and the glomerulus. Editorial review. Kidney Int 1995;48:20-32.
64. Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 1995;96:482-90.
65. Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens 1992;B11:117-29.
66. Committee on Nitrate and Alternative Curing Agents in Food, National Academy of Sciences. The health effects of nitrate, nitrite and n-nitroso compounds. Washington, DC: Natl Acad Press, 1981.
67. Schmidt RJ, LJ Samsell, J Domico, MI Sorkin, C Baylis. Hemodialysis patients (HDP) exhibit reduced plasma nitric oxide levels. Proc XIIIth Int Congr Nephrol (abstracts). 1995: 533.
68. Doerr RC, Fox JB Jr, Lakritz L, Fiddler W. Determination of nitrite in cured meats by chemiluminescence detection. Anal Chem 1981;53:381-4.
69. Kopp L, Paradiz G, Tucci JR. Urinary excretion of cyclic 3′,5′-adenosine monophosphate and cyclic 3′,5′-quanosine monophosphate during and after pregnancy. J Clin Endocrin Metab 1977;44:590-4.
70. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994;171:944-8.
71. Curtis NE, Gude NM, King RG, Marriott PJ, Rook RJ, Brennecke SP. Nitric oxide metabolites in normal human pregnancy and pre-eclampsia. Hypertens Pregnancy 1995;14:339-49.
72. Brown MA, Tibben E, Zammit VC, Cario GM, Carlton MA. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregnancy 1995;14:319-26.
73. (a) Keaney JF, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993;91:1582-9.
74. (b) Conrad KP, Mosher MD. Nitric oxide biosynthesis in normal and pre-eclamptic pregnancies: a preliminary report. J Am Soc Nephrol 1995;6:657.
75. Hytten FE, Cheyne GA. The aminoaciduria of pregnancy. Br J Obstet Gynecol 1992; 79:429-32.
76. Domenech M, Gruppuso PA, Nishino VT, Susa JB, Schwartz R. Preserved fetal plasma amino acid concentrations in the presence of maternal hypoaminoacidemia. Pediatr Res 1986;20:1071-6.
77. Wood MH, O'Sullivan WJ. The orotic aciduria of pregnancy. Am J Obstet Gynecol 1973;116:57-61.
78. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, Saruta T, Kato R. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992;33:41-8.
79. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley, GSTJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993;342:242-3.
80. McCarthy AL, Taylor P, Graves J, Raju SK, Poston L. Endothelium-dependent relaxation of human resistance arteries in pregnancy. Am J Obstet Gynecol 1994; 171:1309-15.
81. Williams DJ, Vallance PJT, Spencer JAD, Neild GH, Imms FJ. Nitric oxide synthase inhibition in human pregnancy and women taking the oral contraceptive pill. J Am Soc Nephrol 1995;6:674.
82. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Consensus report. Am J Obstet Gynecol 1990;163: 1689-1712.
83. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4:700-8.
84. Takeda T. Experimental study on the blood pressure of pregnant hypertensive rats. Jpn Circ J 1964;28:49-54.
85. Ahokas RA, Mercer BM, Sibai B. Enhanced endothelium-derived relaxing factor activity in pregnant, spontaneously hypertensive rats. Am J Obstet Gynecol 1991; 165:801-7.
86. Chu ZM, Beilin LJ. Nitric oxide-mediated changes in vascular reactivity in pregnancy in spontaneously hypertensive rats. Br J Pharmacol 1993;110:1184-8.
87. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316-20.
88. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:1458-66.
89. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, Zhang XJ, Clark DA, Miller MJS. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994;171: 1243-50.
90. Podjarny E, Pomeranz A, Rathaus M, Green J, Gonen O, Shamir R. Effect of l-arginine treatment in pregnant rats with adriamycin nephropathy. Hypertens Pregnancy 1993;12:517-24.
91. Barton JR, Sibai BM, Ahokas RS, Whybrew D, Mercer BM. Magnesium sulphate therapy in preeclampsia is associated with increased urinary cGMP excretion. Am J Obstet Gynecol 1992;167:931-4.
92. G-nitro-L-arginine methyl ester, in conscious rats. Clin Sci 1993;85:175-81.
93. Cameron IT, Van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993;12:85-92.
94. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993;168:1323-30.
95. DeBelder AJ, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP syndrome with nitric oxide honor. Lancet 1995;345:124-5.
96. Hardy E, Rubin PC, Horn EH. Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in pre-eclampsia. Clin Sci 1994;85:195-202.
97. Conrad KP, Vill M, McGuire PG, Dail WG, Davis A. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 1993; 7: 1269-76.
98. Myatt L, Brockman DE, Langdon G, Pollock JS. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 1993;14:373-83.
99. Gude NM, Di Iulio J, Brennecke SP, King RG. Human placental villous nitric oxide synthase activity. Pharmacol Commun 1994;4:163-71.
100. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, Baylis SA, Charles IG. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 1994;311:235-41.
101. 2+-independent NO-synthesizing activities of human primordial placenta. Acta Physiol Hung 1994;82:313-9.
102. Toth M, Kukor Z, Romero R, Hertelendy F. Nitric oxide synthase in first-trimester human placenta: characterization and subcellular distribution. Hypertens Pregnancy 1995;14:287-300.
103. Conrad KP, Davis AK. Nitric oxide synthase activity in placentae from women with preeclampsia. Placenta. [In press]
104. Myatt L, Brockman DE, Eis ALW, Pollock JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993;14:487-95.
105. Buttery LDK, McCarthy A, Springall DR, Sullivan MHF, Elder MG, Michel T, Polak JM. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994;15: 257-65.
106. Kristoffersen EK, Ulvestad E. Nitric oxide synthase in human placenta. APMIS 1994;102:509-13.
107. Springall DR, Riveros-Moreno V, Buttery L, Suburo A, Bishop AE, Merrett M, Moncada S, Polak JM. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992;98:259-66.
108. Eis ALW, Brockman DE, Pollock JS, Myatt L. Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 1995;16:113-26.
109. McLaughlin MK, Conrad KP. Nitric oxide biosynthesis during pregnancy: implications for circulatory changes. Clin Exp Pharmacol Physiol 1995;22:164-71.
110. Gude NM, King RG, Brennecke SP. Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta. Lancet 1990;336:1589-90.
111. Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992;166:224-30.
112. Gude NM, Xie CY, King RG, Brennecke SP, Read MA, Boura ALA, Walters WAW. Effects of eicosanoid and endothelial cell derived relaxing factor inhibition on fetal vascular tone and responsiveness in the human perfused placenta. Trophoblast Res 1993;7:133-45.
113. Wieczorek KM, Brewer AS, Myatt L. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol 1995;173:708-13.
114. Myatt L, Brewer AS, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991;164:687-92.
115. Chang J-K, Roman C, Heymann MA. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am J Obstet Gynecol 1992;166:727-34.
116. Boura ALA, Gude NM, King RG, Walters WAW. Acetylcholine output and foetal vascular resistance of human perfused placental cotyleda. Br J Pharmac 1986;88: 301-6.
117. Read MA, Boura ALA, Walters WAW. Vascular actions of purines in the foetal circulation of the human placenta. Br J Pharmacol 1993;110:454-60.
118. Van de Voorde J, Vanderstichele H, Leusen I. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 1987;60:517-22.
119. Buga GM, Gold ME, Wood KS, Chaudhuri G, Ignarro LJ. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol 1989;161:61-72.
120. Chaudhuri G, Buga GM, Gold ME. Characterization and actions of human umbilical endothelium derived relaxing factor. Br J Pharmacol 1991;102:331-6.
121. 2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol 1993;265: H2036-43.
122. Hull AD, White CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries. Placenta 1994; 15:365-75.
123. Griggs KC, Mackey KR, McLaughlin MK. Human chorionic plate arteries lack an endothelium-dependent relaxation response. Clin Exp Hypertens Pregnancy 1991; B10:21-33.
124. Sexton AJ, Loesch A, Turmiane M, Miah UC, Burnstock G. Nitric oxide and human umbilical vessels: pharmacological and immunohistochemical studies. Placenta 1995;16:277-88.
125. Monuszko E, Halevy S, Freese KJ, Shih HJ, Parikh NS, Jelveh Z, Liu-Barnett M, Cybulska J. Umbilical vessels endothelium and vascular reactivity. Microcirc Endothel Lymph 1990;6:183-208.
126. Wang Y, Walsh SW, Parnell R, Han J. Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies. Hypertens Pregnancy 1994; 13:171-8.
127. Ghabour MS, Eis ALW, Brockman DE, Pollock JS, Myatt L. Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia. Am J Obstet Gynecol 1995;173:687-94.
128. Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, Martinelli P. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991;164:507-13.
129. Akar F, Ark M, Uydes BS, Soysal ME, Saracoglu F, Abacioglu N, Van deVoorde J, Kanzik I. Nitric oxide production by human umbilical vessels in severe preeclampsia. J Hypertens 1994;12:1235-41.
130. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714-8.
131. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and fetoplacental arterial beds. Pharmac Ther 1995;65:215-39.
132. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and preeclampsia. Br J Obstet Gynecol 1996;103:4-15.